Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed in Crash on Nordhoff Street


Driver Hits Tree in Fatal Los Angeles Accident

Los Angeles, CA (April 5, 2020) – A driver was killed in a solo-vehicle crash in Los Angeles. The fatal accident occurred om the morning of April 5 on Nordhoff Street.

A 29-year-old driver lost control of their car in the 16300 block of Nordhoff Street and plowed into a large tree. The driver, the sole occupant of the vehicle, died at the accident scene. 

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Los Angeles

#91343


April 21, 2020

Motorcyclist Injured in Crash on Marsh Creek Road

Motorcycle, SUV Collide in Brentwood Accident...


March 24, 2020

1 Killed in Crash on Interstate 105 Near Long Beach Boulevard

Several Vehicles Collide in Fatal Lynwood Accident ...


October 7, 2019

1 Killed in Crash on Interstate 80 Near Carlson Boulevard

Multiple Vehicles Involved in Fatal Richmond Accident Richmond, CA (October 6, ...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.